Moderna could make experimental COVID-19 vaccine available to healthcare workers by fall

Moderna could make experimental COVID-19 vaccine available to healthcare workers by fall

4 years ago
Anonymous $9CO2RSACsf

https://techcrunch.com/2020/03/23/moderna-could-make-experimental-covid-19-vaccine-available-to-healthcare-workers-by-fall/

There are some hard limits to the vaccine development process that mean we are not going to see any preventative immune therapies to fight the new coronavirus for at least a year to 18 months. But Moderna, which is behind the first potential vaccine to enter human clinical trials in the U.S., provided new info on Monday that indicates it will seek to provide access to the vaccine by as early as this fall, to a limited group likely consisting of healthcare workers.

The company will look at possibly doing so under an emergency use authorization from eh Food and Drug Administration, which is similar to how certain testing procedures are being granted approval for use now, bypassing the typical process under which such diagnostic tools are given the go-ahead. Moderna’s solution which was developed in partnership with the National Institute of Allergy and Infectious Diseases, is already the fastest potential vaccine to enter the human clinical trial phase.

Moderna could make experimental COVID-19 vaccine available to healthcare workers by fall

Mar 23, 2020, 6:26pm UTC
https://techcrunch.com/2020/03/23/moderna-could-make-experimental-covid-19-vaccine-available-to-healthcare-workers-by-fall/ > There are some hard limits to the vaccine development process that mean we are not going to see any preventative immune therapies to fight the new coronavirus for at least a year to 18 months. But Moderna, which is behind the first potential vaccine to enter human clinical trials in the U.S., provided new info on Monday that indicates it will seek to provide access to the vaccine by as early as this fall, to a limited group likely consisting of healthcare workers. > The company will look at possibly doing so under an emergency use authorization from eh Food and Drug Administration, which is similar to how certain testing procedures are being granted approval for use now, bypassing the typical process under which such diagnostic tools are given the go-ahead. Moderna’s solution which was developed in partnership with the National Institute of Allergy and Infectious Diseases, is already the fastest potential vaccine to enter the human clinical trial phase.